MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy

BACKGROUND: The active metabolite of 5-Fluorouracil (5FU), used in the treatment of several types of cancer, acts by inhibiting the thymidylate synthase encoded by the TYMS gene, which catalyzes the rate-limiting step in DNA replication. The major failure of 5FU-based cancer therapy is the developme...

Descripción completa

Detalles Bibliográficos
Autor principal: Matuszyk, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351108/
https://www.ncbi.nlm.nih.gov/pubmed/35922756
http://dx.doi.org/10.1186/s10020-022-00516-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351108/
https://www.ncbi.nlm.nih.gov/pubmed/35922756
http://dx.doi.org/10.1186/s10020-022-00516-2

Ejemplares similares